High PPFIA1 expression promotes cancer survival by suppressing CD8+ T cells in breast cancer: drug discovery and machine learning approach.
Jinah ChuKyueng Whan MinDong-Hoon KimByoung Kwan SonHyung Suk KimUn Suk JungMi Jung KwonSung-Im DoPublished in: Breast cancer (Tokyo, Japan) (2022)
High PPFIA1 in patients with breast cancer is related to poor prognosis and decreased anticancer immune response, and erlotinib may be promising for development of therapeutic approaches in patients with tumors overexpressing PPFIA1.